VETO — Vetoquinol SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Vetoquinol SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	368	396	427	521	540
Cost of Revenue
Gross Profit	225	237	260	323	334
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	320	355	390	435	466
Operating Profit	48.2	40.9	37.1	86.3	74
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	48.6	40.7	35.6	86.5	72.7
Provision for Income Taxes
Net Income After Taxes	36.4	28.2	18.9	62.7	48
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	36.3	28.6	19.2	62.9	48
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	36.3	28.6	19.2	62.9	48
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.07	2.72	2.48	5.37	4.63
Dividends per Share